The STEP 8 trial: direct comparison The STEP 8 trial is the most important study for this comparison because it pitted semaglutide 2.4 mg weekly directly against liraglutide 3.0 mg daily in adults with overweight or obesity but without diabetes
Statins remain the most effective medication for lowering LDL cholesterol and reducing cardiovascular risk
And we learned through that process working on this committee that you were the one to be the champion of pushing this towards obesity, and it would've easily been missed because as we've been discussing, the weight loss in people with diabetes was small, but you push for it
The optimal dosage for men is between 40 and 50 mcg of IGF1 LR3, while for women, the dosage should remain within the 20 mcg bracket
Check with your specific insurance plan about telehealth prescription coverage
The study adds on additional data to what weve already previously known about GLP-1 containing agents: these drugs hope to reduce risk for cardiovascular complications from obesity, said Yu-Ming Ni, MD, a cardiologist and lipidologist at MemorialCare Heart and Vascular Institute at Orange Coast Medical Center in Fountain Valley, CA